Is there a relationship between ELF free-IGF-1 levels and fibrotic process enhancement characterizing CLD development in neutropenic premature babies?
Capoluongo
Ettore
E
Concolino
Paola
P
Giardina
Bruno
B
Zuppi
Cecilia
C
Ameglio
Franco
F
Vento
Giovanni
G
Romagnoli
Costantino
C
D015415:Biomarkers / Q000032:analysis; D001997:Bronchopulmonary Dysplasia / Q000097:blood / Q000175:diagnosis*; D018450:Disease Progression; D036383:Ephrin-A2 / Q000378:metabolism*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000175:diagnosis; D011658:Pulmonary Fibrosis / Q000097:blood / Q000175:diagnosis*; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000175:diagnosis*; D012178:Retinopathy of Prematurity / Q000097:blood / Q000175:diagnosis; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D015415:Biomarkers; D036383:Ephrin-A2; D007334:Insulin-Like Growth Factor I